Gene Symbol | PRR19 |
---|---|
Entrez Gene | 284338 |
Alt Symbol | - |
Species | Human |
Gene Type | protein-coding |
Description | proline rich 19 |
Other Description | proline-rich protein 19 |
Swissprots | B3KW48 A6NJB7 A8K663 Q6P584 |
Accessions | A6NJB7 EAW57127 AI208291 AK124116 BAG54010 AK291528 BAF84217 AW451766 BC063021 AAH63021 BM762502 XM_005258779 XP_005258836 XM_005258780 XP_005258837 XM_006723154 XP_006723217 XM_011526787 XP_011525089 XM_011526788 XP_011525090 XM_011526789 XP_011525091 XM_011526790 XP_011525092 NM_199285 NP_954979 |
PRR19 CRISPR/Cas9 KO Plasmid (h) - sc-408652 from Santa Cruz Biotechnology
|
||||||||
PRR19 HDR Plasmid (h) - sc-408652-HDR from Santa Cruz Biotechnology
|
||||||||
PRR19 Double Nickase Plasmid (h) - sc-408652-NIC from Santa Cruz Biotechnology
|
||||||||
PRR19 Double Nickase Plasmid (h2) - sc-408652-NIC-2 from Santa Cruz Biotechnology
|
||||||||
PRR19 CRISPR Activation Plasmid (h) - sc-408652-ACT from Santa Cruz Biotechnology
|
||||||||
PRR19 CRISPR Activation Plasmid (h2) - sc-408652-ACT-2 from Santa Cruz Biotechnology
|
||||||||
PRR19 Lentiviral Activation Particles (h) - sc-408652-LAC from Santa Cruz Biotechnology
|
||||||||
PRR19 Lentiviral Activation Particles (h2) - sc-408652-LAC-2 from Santa Cruz Biotechnology
|
||||||||
MGC70924 siRNA (h) - sc-97213 from Santa Cruz Biotechnology
|
||||||||
MGC70924 shRNA Plasmid (h) - sc-97213-SH from Santa Cruz Biotechnology
|
||||||||
MGC70924 shRNA (h) Lentiviral Particles - sc-97213-V from Santa Cruz Biotechnology
|
||||||||
MISSION® esiRNA - EHU121321 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN17495 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND17495 from Sigma-Aldrich
|
||||||||
PRR19 siRNA (Human) - CRJ6998 from Cohesion Biosciences
|
||||||||
shRNA set against Human PRR19 (NM_199285.2) - SHH384036 from Creative biogene
|
||||||||
PRR19 shRNA Plasmid (Human) - CHJ6998 from Cohesion Biosciences
|
||||||||
PRR19 miRNA 3'UTR clone - MiUTR1H-06291 from Creative biogene
|
||||||||